Recent Advances and Future Strategies for Small Cell Lung Cancer
10.3779/j.issn.1009-3419.2017.06.09
- VernacularTitle:小细胞肺癌目前治疗的策略与未来方向
- Author:
SHAO WEIPENG
1
;
WANG XIAOWEI
;
LIU DERUO
Author Information
1. 北京大学中日友好临床医学院胸外科
- Keywords:
Lung neoplasms;
Surgery;
Chemotherapy;
Radiotherapy;
Target therapy;
Immunotherapy
- From:
Chinese Journal of Lung Cancer
2017;20(6):421-426
- CountryChina
- Language:Chinese
-
Abstract:
Small cell lung cancer (SCLC) is a malignant tumor with a very high mortality rate. The current standard of care includes surgery, chemotherapy and radiotherapy. The clinical benefit of therapies was disappointing. Recently, many clinical trials about target therapy and immunotherapy are processing. This review will focus on current therapy and future re-search direction of SCLC.
